Holen Sie sich die Stockscreener-App
10.08
0.10%
-0.010
Handel nachbörslich:
10.08
Schlusskurs vom Vortag:
$10.09
Offen:
$10.08
24-Stunden-Volumen:
416.76K
Relative Volume:
0.83
Marktkapitalisierung:
$1.44B
Einnahmen:
$6.32B
Nettoeinkommen (Verlust:
$230.14M
KGV:
10.50
EPS:
0.9598
Netto-Cashflow:
$256.03M
1W Leistung:
-6.32%
1M Leistung:
+8.15%
6M Leistung:
+13.64%
1J Leistung:
-29.36%
1-Tages-Spanne:
$9.90
$10.29
1-Wochen-Bereich:
$9.82
$11.03
52-Wochen-Spanne:
$7.71
$15.48
Ardent Health Inc Stock (ARDT) Company Profile
Firmenname
Ardent Health Inc
Sektor
Branche
Telefon
(615) 296-3000
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDT
Ardent Health Inc
|
10.08 | 1.44B | 6.32B | 230.14M | 256.03M | 0.9598 |
HCA
Hca Healthcare Inc
|
406.59 | 90.20B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
204.25 | 17.59B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
232.80 | 14.94B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.02 | 12.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
110.16 | 10.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-09-10 | Eingeleitet | UBS | Buy |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-12 | Eingeleitet | BofA Securities | Buy |
| 2024-08-12 | Eingeleitet | Citigroup | Buy |
| 2024-08-12 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2024-08-12 | Eingeleitet | Loop Capital | Buy |
| 2024-08-12 | Eingeleitet | Mizuho | Outperform |
| 2024-08-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-08-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-12 | Eingeleitet | Stephens | Overweight |
| 2024-08-12 | Eingeleitet | Truist | Buy |
Alle ansehen
Ardent Health Inc Aktie (ARDT) Neueste Nachrichten
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RBC Adjusts Price Target on Ardent Health Partners to $12 From $13, Maintains Outperform Rating - Moomoo
BofA Securities Adjusts Ardent Health Partners Price Target to $9.50 From $9 - Moomoo
Does Ardent Health's (ARDT) Russell Growth Exit Hint At A Shift In Its Investor Base? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
ARDT Deadline: Rosen Law Firm Urges Ardent Health, Inc. (NYSE: AR - The National Law Review
ARDTArdent Health Inc Options - Finviz
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Form 4 Ardent Health Partners LLC For: 2 July By Investing.com - Investing.com Canada
Ardent Health (ARDT) CEO Dave Caspers awarded 103,653 RSUs in equity grant - Stock Titan
Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare
Is Ardent Health Poised For A Turnaround After A Plunge From Its 52-Week High? - RTTNews
Do options traders know something about Ardent Health stock we don't? - MSN
Ardent Health CEO Separation Agreement Finalizes Leadership Transition - The Globe and Mail
Ardent Health (NYSE: ARDT) files former CEO separation agreement - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
2026-06-30 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Stockholders to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Ardent Health, Inc.(NYSE:ARDT) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Ardent Health, Inc.(NYSE: ARDT) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Investors to Inquire about Securities Investigation - ACCESS Newswire
Do Options Traders Know Something About Ardent Health Stock We Don't? - TradingView
Ardent Health, Inc.(NYSE: ARDT) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Ardent Health, Inc.(NYSE: ARDT) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Does Ardent Health (ARDT) Falling Out of Russell Growth Indexes Reveal a Shifting Investor Base? - simplywall.st
ETFs Investing in Ardent Health, Inc. Stocks - TradingView
Ardent Health, Inc.(NYSE: ARDT) dropped from Russell 3000 Growth Benchmark - marketscreener.com
ARDENT HEALTH INC (ARDT) Stock Chart - ChartMill
Ardent Health, Inc. Actuals & Estimates (NYSE:ARDT) - TradingView
ARDT Forecast — Price Target — Prediction for 2027 - TradingView
ARDT Q1 2026 Earnings: Significant EPS Beat Drives Positive Market ReactionManagement Tone Analysis - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ardent Health, Inc. (ARDT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Ardent Health Partners Inc (ARDT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2026-06-21 | Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Shareholders to Inquire about Securities Investigation | NYSE:ARDT | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Shareholders to Connect - ACCESS Newswire
Ardent Health Partners Inc (ARDT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ardent Health Partners Inc (ARDT) Institutional Confidence - TradingKey
Ardent Health Partners Inc (ARDT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ardent Health Partners Inc (ARDT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ardent Health Partners Inc (ARDT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ardent Health Partners Inc (ARDT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ardent Health Partners Inc (ARDT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ardent Health, Inc. (ARDT) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-06-14 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Is Ardent Health’s (ARDT) New CEO Appointment a Turning Point for Its Efficiency-Led Strategy? - Sahm
Ardent Health (ARDT) Slips 3% as Stock Tests Support Levels Amid Sector WeaknessKey Reversal Day - newsline.com
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $12 to $13.5 - Moomoo
Ardent Health (ARDT) Slips 3.31% as Resistance Holds, Support Near $8.88 in FocusPullback Trade - newsline.com
Ardent Health (ARDT) Slips 3.31% as Stock Tests Key Support LevelsHedge Fund Exposure - newsline.com
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares? - Yahoo Finance
Finanzdaten der Ardent Health Inc-Aktie (ARDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):